Drug recall

Acetaminophen 325 mg tablets, packaged in a) 100-count bottle (NDC 71399-8024-01); b) 1000-count bottle (NDC…

FDA recall event 90682 · Class III · Akron Pharma, Inc.

Key facts

Event ID 90682
Recall numbers D-1352-2022, D-1353-2022
Recalling firm Akron Pharma, Inc.
Product type Drugs
Products Acetaminophen 325 mg tablets, packaged in a) 100-count bottle (NDC 71399-8024-01); b) 1000-count bottle (NDC 71399-8024-02), Akorn Pharma Manufactured for: Akorn Pharma, Inc., Fairfield, NJ, Acetaminophen 500 mg tablet, Extra Strength, packaged in a) 100-count bottle (NDC 71399-8022-01), b) 1000-count bottle (NDC 71399-8022-02), Akorn Pharma Manufactured for: Akorn Pharma, Inc…
Classification Class III
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.
Initiation date Aug 4, 2022
Report date Aug 24, 2022
Termination date Dec 4, 2023
City Fairfield
State NJ
Country United States
FEI number 3013943804

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls